FAF
BIO icon

Första AP-fonden’s Bio-Rad Laboratories Class A BIO Stock Holding History

Första AP-fonden’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,500
Closed -$2.23M – 586
2022
Q2 		$2.23M Buy
+4,500
New +$2.34M 0.03% 500
2021
Q4 		– Sell
-3,400
Closed -$2.54M – 563
2021
Q3 		$2.54M Buy
+3,400
New +$2.55M 0.03% 486
2021
Q1 		– Sell
-2,600
Closed -$1.52M – 531
2020
Q4 		$1.52M Buy
+2,600
New +$1.48M 0.02% 484
2020
Q3 		– Sell
-2,900
Closed -$1.31M – 524
2020
Q2 		$1.31M Buy
2,900
+2,300
+383% +$1.01M 0.03% 467
2020
Q1 		$210K Buy
+600
New +$221K 0.01% 469

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return